Who gets genomic testing for breast cancer recurrence risk?
Who gets genomic testing for breast cancer recurrence risk?
复制标题
DOI:
10.1159/000353518
复制
发表时间:
2013
影响因子:
1.7
通讯作者:
Brewer NT
中科院分区:
文献类型:
--
作者:
DeFrank JT;Salz T;Reeder-Hayes K;Brewer NT
Our study examined whether patient characteristics, beliefs, and decision-making styles were associated with uptake of genomic testing for breast cancer recurrence risk. Participants were 132 early-stage breast cancer patients eligible for the Oncotype DX genomic test. We interviewed patients in 2009–2010 and obtained information from medical charts. Half of women eligible for genomic testing for breast cancer recurrence risk received it. The most common reason for not getting the test was that women’s physicians did not offer it (80%). Test recipients were more likely to be unsure about receiving chemotherapy treatment compared to women who did not receive the test (p<.05). Women who received the test had less advanced disease pathologies, recalled a lower objective recurrence risk, perceived lower recurrence risk and were slightly younger (all p<.05). Most women who described their decision-making style as active received the test (75%) whereas few women who described their style as passive received the test (12%) (p<.01). In the university clinic we studied, genomic testing appeared to more common among patients who may benefit most from the information provided by results, but confirmation in larger studies is needed.
登录
查看更多内容
影响因子:
6.2
作者:
Lund, Mary Jo;Mosunjac, Marina;O'Regan, Ruth M.
通讯作者:
O'Regan, Ruth M.
影响因子:
5.8
作者:
Paik, Soonmyung
通讯作者:
Paik, Soonmyung
影响因子:
45.3
作者:
Hassett, Michael J.;Silver, Samuel M.;Weeks, Jane C.
通讯作者:
Weeks, Jane C.
影响因子:
45.3
作者:
Bruera, E;Sweeney, C;Benisch-Tolley, S
通讯作者:
Benisch-Tolley, S
影响因子:
5.5
作者:
Frosch, DL;Kaplan, RM
通讯作者:
Kaplan, RM